A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms.

Trial Profile

A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms.

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Aug 2012

At a glance

  • Drugs Orlistat (Primary)
  • Indications Obesity; Overweight
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 11 Aug 2012 New source identified and integrated (European Clinical Trials Database: EudraCT2008-006986-10).
    • 20 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top